3 terminated, 2 completed, 2 unknown, 1 recruiting. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 3, Completed 2, Unknown 2, Recruiting 1 |
Follow Cancer of Stomach: new trials by email Literature Review of Cancer of Stomach trials Research Report on Cancer of Stomach
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder Psilocybin therapy - Adjustment Disorder, Adjustment Disorder With Anxious Mood | Phase 2 | Recruiting | Psyence Australia Pty Ltd | 87 | 2025-10-01 | 2026-03-03 |
| A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) IMU-131, Ramucirumab plus Paclitaxel, Pembrolizumab - Gastric Cancer, Cancer of Stomach | Phase 2 | Terminated | Imugene Limited | 7 | 2022-08-17 | 2025-05-11 |
| Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy AZD2014 - Cancer of Stomach | Phase 2 | Terminated | Samsung Medical Center | 1 | 2017-02-01 | 2019-05-20 |
| Maintenance Treatment With S-1 in Gastric Cancer Patients S-1 maintenance, Observation - Gastric Cancer Stage IV, Cancer of Stomach | Phase 2 | Unknown | Sun Yat-sen University | 200 | 2016-01-01 | 2018-10-10 |
| NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma nab-paclitaxel, FOLFOX - Cancer of Stomach | Phase 2 | Unknown | GERCOR - Multidisciplinary Oncology Cooperative Group | 55 | 2015-06-01 | 2019-02-27 |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 ASLAN001 - Stomach Neoplasms, Cancer of Stomach | Phase 2 | Completed | ASLAN Pharmaceuticals | 24 | 2012-03-01 | 2015-01-14 |
| Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction Pegamotecan - Cancer of Stomach, Gastroesophageal Cancer | Phase 2 | Terminated | Enzon Pharmaceuticals, Inc. | 2003-12-01 | 2012-09-06 | |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer CPT-11, Mitomycin C - Esophageal Cancer, Esophagus Cancer | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 80 | 2001-09-01 | 2017-12-06 |
Stomach Neoplasms (8) · Neoplasms (2) · Adjustment Disorders (1) · Breast Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Kidney Neoplasms (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
Digestive System Diseases (8) · Digestive System Neoplasms (8) · Gastrointestinal Diseases (8) · Gastrointestinal Neoplasms (8) · Neoplasms by Site (8) · Stomach Diseases (8) · Neoplasms (6) · Breast Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Folfox protocol (1) · Irinotecan (1) · Mitomycin (1) · Observation (1) · Paclitaxel (1) · Ramucirumab (1) · pegamotecan (1) · pembrolizumab (1) · vistusertib (1)
ASLAN Pharmaceuticals (1) · Enzon Pharmaceuticals, Inc. (1) · GERCOR - Multidisciplinary Oncology Cooperative Group (1) · Imugene Limited (1) · Ohio State University Comprehensive Cancer Center (1) · Psyence Australia Pty Ltd (1) · Samsung Medical Center (1) · Sun Yat-sen University (1)
Australia (2) · South Korea (2) · China (1) · France (1) · Taiwan (1) · United States (1)
Clive Ward-Able (1) · Miguel Villalona, MD (1) · Rui-hua Xu (1) · Seock-Ah Im, Dr. (1)